Challenges of Clinical Trial for Alzheimer’s
Alzheimer’s Speaks Radio
Talks with Dr. Elliot Goldstein on the
Challenges of Clinical Trial for Alzheimer’s
Live Tuesday, April 3rd, 2018 –
2pm EST, 1pm CST, 12pm MST, 11am PST, 7pm London
Today we are going to talk with Dr. Elliot Goldstein, with ProMIS Neurosciences about a highly awaited Phase 3 trial and the challenges in Alzheimer’s drug development. Dr. Goldstein brings a unique track record in the clinical, regulatory and commercial development of new pharmaceuticals. He spent 14 years on drug development around the world, including being Head of Clinical R&D in the United States. Dr Goldstein has also held positions as Senior VP of Strategic Product Development, Chief Operating Officer and Chief Medical Officer and President and CMO in the pharma industry.
Contact Information:
Website: www.promisneurosciences.com
Additional information on ProMIS:
http://www.bioworld.com/report/BWIS03052018PromisNeurosciences.pdf
Looking for a Speaker?
See what LeadingAge has to say
about Lori La Bey
“Feedback from the conference planning committee and our leadership team was extremely positive. Many attendees commented that she was one of the best speakers they had heard.”
Pat Sylvia, Director of Education & Member Development LeadingAge Washington
Meet Lori La Bey in April
Click Below to Download the Tips
Push Research Forward – Join the A-List
